Clinical trial
Psilocybin for the Treatment of Major Depressive Disorder
NCT05675800 is registered in ClinicalTrials.gov with Washington University School of Medicine as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Psilocybin for the Treatment of Major Depressive Disorder
- Lead sponsor
- Washington University School of Medicine
- Phase
- Phase 2
- Overall status
- Withdrawn
- Start date
- January 1, 2024
- Completion date
- March 31, 2025
- Enrollment
- 0 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.